MOREPENLABNSEMorepen Laboratories Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Mon, 5 May, 2025 · 16:08 IST

Morepen Laboratories Limited has informed the Exchange about change in Senior Management Personnel on account of resignation.

Kmp ResignedManagement Changes View source PDFExplain this filing

MOREPENLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.6%Reaction day
₹60.89
prior close
₹60.89
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-2.6%-3.0% vs market
Pharmaceuticals peers, median of 147sector-2.3%-3.3% vs sector

On the reaction day the stock moved 3.0 pts less than Nifty Microcap 250 and 3.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.6
10m
-1.5
15m
-1.6
30m
-1.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.6-2.6-3.0-2.3-3.3
Next day
-3.4-1.4-2.0-1.8-1.5
2d
-6.5-2.2-4.3-3.0-3.5
3d
-6.4-2.3-4.1-3.6-2.8
4d
-0.6+2.2-2.8-0.3-0.3
5d
-1.4+3.9-5.3+0.9-2.3
1w
-0.0+6.6-6.6+2.6-2.6
15d
+9.4+9.5-0.2+4.5+4.8
1m
+5.8+11.4-5.6+3.5+2.4
2m
+4.6+13.8-9.2+6.0-1.4
3m
-13.3+9.9-23.2+2.3-15.5
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Morepen Laboratories informed the exchanges that Mr. Naresh Sharma, Vice President – Operations (API) and Factory Manager, has resigned due to personal reasons, effective May 5, 2025. The disclosure was made under Regulation 30 of the SEBI Listing Regulations, along with the resignation email as supporting evidence. Mr. Sharma's email cited unavoidable personal circumstances as the reason for stepping down. No replacement or interim arrangement has been mentioned in this filing.

Likely market impact

This is a mid-to-senior operational-level exit rather than a top leadership change, so the direct impact on stock price or shareholder value is likely limited. Investors may watch for any disruption in API operations or a timely successor appointment, but the resignation itself is routine in nature.